Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linezolid-associated toxic optic neuropathy.

J C Rucker1, S R Hamilton, D Bardenstein

  • 1Department of Neurology, Rush University Medical Center, Chicago, IL 60612, USA. janet_rucker@rush.edu

Neurology
|March 1, 2006
PubMed
Summary

Linezolid, an antibiotic for gram-positive infections, can cause optic and peripheral nerve damage with prolonged use. This neural toxicity may stem from impaired mitochondrial protein synthesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compound heterozygous PNPLA6 mutations cause Boucher-Neuhäuser syndrome with late-onset ataxia.

Journal of neurology·2014
Same author

Spirochetosis in turkeys (a preliminary report).

Journal of the American Veterinary Medical Association·2010
Same author

Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome.

Neurology·2009
Same author

Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials.

Neurology·2009
Same author

Pain in ischaemic ocular motor cranial nerve palsies.

The British journal of ophthalmology·2009
Same author

Neuromuscular junction dysfunction in Miller Fisher syndrome.

Seminars in ophthalmology·2008

Area of Science:

  • Pharmacology
  • Neuroscience
  • Infectious Diseases

Background:

  • Linezolid is a crucial oxazolidinone antibiotic for treating gram-positive bacterial infections.
  • Recommended treatment duration is typically 28 days, but longer courses are frequently administered.

Observation:

  • Prolonged linezolid therapy, exceeding 28 days, is associated with neurological side effects.
  • Cases of reversible optic neuropathy and irreversible peripheral neuropathy have been reported.

Findings:

  • This report details three cases of combined optic and peripheral neuropathy induced by linezolid.
  • A review of existing literature on linezolid-induced optic neuropathy is included.
  • Mitochondrial protein synthesis impairment is a potential mechanism for linezolid's neurotoxicity.

Related Experiment Videos

Implications:

  • Clinicians should be vigilant for neurological symptoms in patients on extended linezolid treatment.
  • Understanding the mechanism of neurotoxicity may inform safer antibiotic prescribing practices.
  • Further research into mitochondrial dysfunction could lead to strategies mitigating linezolid-induced nerve damage.